WHO ICTRP trial
Thioguanine Suppositories For Proctitis
ACTRN12616000602426 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12616000602426 |
|---|---|
| Public title | Thioguanine Suppositories For Proctitis |
| Scientific title | Thioguanine Suppositories For Proctitis. An Open Label Phase I Study To Evaluate the Efficacy and Safety of TG as a suppository |
| Primary sponsor | Mater Hospital Brisbane |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | inflammatory bowel disease (IBD);proctitis; inflammatory bowel disease (IBD) proctitis;Oral and Gastrointestinal - Inflammatory bowel disease |
| Interventions | The overall aim of the current study is to evaluate the safety and efficacy of low dose thioguanine 20mg suppositories in an open-label phase I study involving up to 10 patients with severe proctitis, who are unresponsive to the current… |
| Registration date | Oct 5, 2016 |
| Target size | 10 |
| Secondary IDs | nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: